The association between polypharmacy, frailty and disability-free survival in community-dwelling healthy older individuals
- 23 March 2022
- journal article
- research article
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 101, 104694
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Health and Medical Research Council
This publication has 44 references indexed in Scilit:
- Measurement of Disability-free Survival after SurgeryAnesthesiology, 2015
- Health Outcomes Associated with Polypharmacy in Community‐Dwelling Older Adults: A Systematic ReviewJournal of the American Geriatrics Society, 2014
- Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trialContemporary Clinical Trials, 2013
- The frailty phenotype and the frailty index: different instruments for different purposesAge and Ageing, 2013
- Clinical implications from drug–drug and drug–disease interactions in older peopleClinical and Experimental Pharmacology and Physiology, 2013
- Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomesJournal of Clinical Epidemiology, 2012
- Geriatric Syndromes: Clinical, Research, and Policy Implications of a Core Geriatric ConceptJournal of the American Geriatrics Society, 2007
- Effects of a Physical Activity Intervention on Measures of Physical Performance: Results of the Lifestyle Interventions and Independence for Elders Pilot (LIFE-P) StudyThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2006
- A global clinical measure of fitness and frailty in elderly peopleCanadian Medical Association Journal, 2005
- Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV)American Journal of Psychiatry, 1995